Replimune Group, Inc. (REPL) Misses Q4 EPS by 235c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($3.07), $2.35 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Cinema United: issues joint letter to state AGs and Paramount
• Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
• Boeing-Lockheed space venture inks $1.5 billion private bonds - Bloomberg